Megna, M., Ruggiero, A., Martora, F., Vallone, Y., Guerrasio, G., & Potestio, L. (2024). Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study. Journal of Clinical Medicine, 13(9), 2691. https://doi.org/10.3390/jcm13092691
Chicago Style (17th ed.) CitationMegna, Matteo, Angelo Ruggiero, Fabrizio Martora, Ylenia Vallone, Gianluca Guerrasio, and Luca Potestio. "Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study." Journal of Clinical Medicine 13, no. 9 (2024): 2691. https://doi.org/10.3390/jcm13092691.
MLA (9th ed.) CitationMegna, Matteo, et al. "Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study." Journal of Clinical Medicine, vol. 13, no. 9, 2024, p. 2691, https://doi.org/10.3390/jcm13092691.
